The type segmentation of the MEMS‑Based Biosensors market is organized around the transduction mechanism, each offering distinct performance attributes that influence adoption rates. Electrochemical sensors, prized for low power consumption and compatibility with miniaturized circuitry, represent the largest share at approximately 40 %, especially in glucose monitoring and pathogen detection. Optical biosensors—leveraging interferometry, fluorescence or surface plasmon resonance—capture around 30 % of the market, favored in high‑throughput laboratory settings where sensitivity and multiplexing are paramount. Piezoelectric devices, which translate mass changes into frequency shifts, hold a 20 % share, finding niche use in label‑free detection of biomolecular interactions. Thermal biosensors, employing temperature‑dependent resistance changes, account for the remaining 10 %, primarily in industrial environments where robust, temperature‑stable operation is required. The relative contributions of these type sub‑segments reflect a balance between cost, integration complexity, and application‑specific performance demands, guiding R&D investment and product‑portfolio strategies.